This article was originally published in SRA
UUS FDA to reclassify medical device data system as low-risk
You may also be interested in...
Look! Up in the sky! It’s a bird! It’s a plane! It’s … a COVID-19 test from Quest Diagnostics.
New directors at 4D Pharma, Neurogene And Zogenix.
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.